
A new injection, which was developed by ViiV Healthcare, has been approved by the U.S. health authority to give protection against HIV, UN News reported. The injection’s main active ingredient is cabotegravir, which will help to offer two months of HIV protection. “But we need urgent action to ensure people everywhere can benefit,” Philippe Duneton, UNITAID executive director said.